More on CDMOP
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $25.06 |
|
|||
| Open | $0.00 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $25.06 | ||||
| Day Low | $25.06 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 184,087 | ||||
- Avid Bioservices (CDMO) Receives Nasdaq Non-compliance Notice
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q
- Avid Bioservices (CDMO) Announces Pricing of Private Placement of Convertible Notes
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024
- Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023
- Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2024 After Market Close on December 7, 2023
- Avid Bioservices Partners With California Institute for Regenerative Medicine (CIRM) to Provide CDMO Services for Cell and Gene Therapy (CGT) Programs
- Avid Bioservices Completes Construction of New, World-Class Cell and Gene Therapy Development and Manufacturing Facility
Entities mentioned with CDMOP
- Earnings | View Related Stories »
- Dividend | View Related Stories »
- Definitive Agreement | View Related Stories »
- S3 | View Related Stories »
- RBC Capital | View Related Stories »
- Stephens Inc. | View Related Stories »
- FDA | View Related Stories »
- Wells Fargo | View Related Stories »
- Show More...
